Practice guidelines for non-small cell lung cancer

Cancer Journal from Scientific American

Volumn 2, Issue 9999, 1996, Pages

  Cameron, Robert ^a   Fringer, Joanna ^b   Taylor, Cat ^c   Gilden, Ron ^d   Figlin, Robert A ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IQ Solutions   (United States)

^c Preferred Oncol Networks of America   (United States)

^d CDP Services   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PATHOLOGY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; QUALITY OF LIFE;

EID: 0346605767     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
2. Samet JM. The epidemiology of lung cancer. Chest. 1993; 103[suppl]:20S-29S.
3. Shepherd FA Future directions in the treatment of non-small cell lung cancer, Department of Medicine, Toronto Hospital, Ontario, Canada. Semin Oncol 1994;21[suppl 4]:48-62.
4. Ihde DC, Minna JD. Uniformed Services University of the Health Sciences, Bethesda, Maryland. Non-small cell lung cancer. Part II: Treatment. Curr Probl Cancer 1991;15:105-154.
5. Faber LP. Lung Cancer. In: American Cancer Society Textbook of Clinical Oncology. Atlanta: American Cancer Society, 1991:194-212.
6. Mountain CF. A new international staging system for lung cancer. Chest 1986;89[suppl]:225S-233S.
7. Strauss GM, Langer MP, Elias AD, Skarin AT, Sugarbaker DJ. Multimodality treatment of stage HIA non-small cell lung carcinoma: a critical review of the literature and strategies for future research. J Clin Oncol 1992;10:829-838.
8. Cybulsky IJ, Bennett WF. Mediastmoscopy as a routine outpa-tient procedure. Ann Thorac Surg 1994;58:176-178.
9. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients. Eur J Cardiothorac Surg 1994;8:37-42.
10. Vestring T, Achatzy R, Wahlers B, Macha HN, Peters PE. Mediastinal staging of non-small cell bronchial carcinoma. The place of computed tomography and mediastinoscopy. Radiologe 1990;30:178-184.
11. Luke WP, Pearson FG, Todd TR, Patterson GA, Cooper JD. Prospective evaluation of mediastinoscopy fot assessment of carcinoma of the lung. J Thorac Cardiovasc Surg 1986;91:53-56.
12. Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients wim primary lung cancer. Ann Thorac Surg 1985;40:556-560.
13. Vallieres E, Waters PF. Incidence of mediastinal node involvement in clinical T1 bronchogenic carcinomas. Can J Surg 1987; 30:341-342.
14. Sandier AB, Buzaid AC. Lung cancer: a review of current therapeutics. Lung 1992;170:249.
15. Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 1989;16:247-255.
16. Holmes EC. Current status of adjuvant chemotherapy in the treatment of non-small cell lung cancer. Important Adv Oncol 1988:259-272.
17. Mountain CF, Lukeman JM, Hammar SP, et al. Lung classification: the relationship of disease extent and cell type to survival in a clinical trials populations. J Surg Oncol 1987;35:147-156.
18. Roth JA, Fossella F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994;86:673-680.
19. Cybulsky IJ, Lanza LA, Ryan MB, Putnam JB Jr, McMurtrey MM, Roth JA. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg 1992;54:533-537.
20. Rosell R, Gomez-Codina J, Camps. A randomized trial comparing preoperative chemotherapy surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330:153-158.
21. Komaki R, Cox JD, Hartz AJ, Survivors after treatment for inoperable carcinoma of characteristics of long-term the lung. Am J Clin Oncol 1985;8:362-370.
22. Schaake-Koning, Van dan Bogaert, Dalesio, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992;326:524-529.
23. Haraf DJ, Devine S, Ihde DC, Yokes EE. The evolving role of systemic therapy in carcinoma of the lung. Semin Oncol 1992; 19[suppl 11]:72-87.
24. Weick JK, Crowley J, Natale RB et al. Randomized trial of five cisplatin-containing treatments in patients with metastatic non-small cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 1991;9:1157-1162.
25. Gandara DR, Crowley J, Livingston RB et al. Evaluation of cisplatin intensity in metastatic non-small cell lung cancer: a Phase III study of the Southwest Oncology Group. J Clin Oncol 1993;11: 873-878.
26. Johnson D, Levitt M, Mason B et al. A Phase II trial of filgrastim (r-metHuG-CSF) as an adjunct to cisplatin and etoposide chemo-therapy in locally advanced or metastatic non-small cell lung carci-noma (NSCLC)[abstract]. Proc Am Soc Clin Oncol 1993; 12: A1131.
27. O'Connell JP, Kris MG, Gralla RJ et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy. J Clin Oncol 1986;4:1604-1614.
28. Recchia F, DeFilippis S, Rea S, Corrao G, Frati L. Cisplatin (CDDP), vindesine (V), 5-fluoruoracil (FU), beta Interferon (IFN) and retinyl palmirate (R) in advanced non-small cell lung cancer (NSCLC). A Phase II study [abstract]. Proc Am Soc Clin Oncol 1993;12:A1144.
29. McDonald S, Chang AY, Rubin P et al. Combined Betaseron R (recombinant human Interferon beta) and radiation for inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27: 613-619.
30. Yang S, Grimm E, Hong W, Parkinson D, Roth J. Immunologic effects of combined immunotherapy with OKT3, mterleukin-2 (IL-2), and tumor necrosis factor-alpha (TNF) in patients with non-small cell lung cancer (NSCLC)[abstract]. Proc Am Soc Clin Oncol 1990;9:A959.
31. Cartei G, Cartei F, Cantone A et al. Cisplatin-cyclophosphamidemitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small cell lung cancer. J Natl Cancer Inst 1993;85:794-800.
32. Hollen PJ, Gralla RJ, Kris MG, Cox C. Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS). Supportive Care in Cancer 1994;2:213-222.
33. Sarna L. Women with lung cancer: impact on quality of life. Qual Life Res 1993;2:13-22
34. Sarna LP. Impact of chemotherapy on the quality of life and functional status of older adults with non-small cell lung cancer. Diss Abstr Int [B] 1990;51:1748.